Virus Like Particles (VLP) as multivalent vaccine candidate against Chikungunya, Japanese Encephalitis, Yellow Fever and Zika Virus
Himanshu Garg(Gold Coast Hospital), Anjali Joshi(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cited by 89
Related Papers
Bronchiectasis in India: results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry
|The Lancet Global Health|2019|236
Clinical outcomes of bronchiectasis in India: data from the EMBARC/Respiratory Research Network of India registry
|European Respiratory Journal|2022|97